SEC filings and other documents

Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

2026

Earnings, Q1 FY2026

Jun 4, 2026

Q1 2026 revenue grew 113% to $12.1M, but net loss widened to $17.7M amid rapid expansion.

Corporate presentation

Jun 4, 2026

VivistimⓇ therapy drives transformative stroke recovery, fueling rapid growth and market expansion.

Mobia Medical, Inc.

SEC filings and other documents